Back
Top 0.3%
23.0%
Top 0.3%
12.2%
Top 65%
8.1%
Top 0.3%
6.1%
Top 1%
6.1%
Top 7%
5.2%
Top 25%
4.3%
Top 0.6%
4.0%
Top 0.9%
4.0%
Top 73%
2.9%
Top 48%
2.0%
Top 13%
1.6%
Top 0.3%
1.6%
Top 8%
1.4%
Top 1.0%
1.2%
Top 1%
1.2%
Top 6%
0.7%
Prognostic value of tumor-informed ctDNA in HPV-independent head and neck squamous cell carcinoma
2026-01-12
oncology
Title + abstract only
View on medRxiv
Show abstract
Importance: Recurrence rates for locally advanced HPV-independent (HPV-) head and neck squamous cell carcinoma (HNSCC) are high. Circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assays have shown promise to improve management and surveillance in several tumor types, but their clinical utility in HPV- HNSCC remains understudied. Objective: To evaluate the performance of a tumor-informed ctDNA-based MRD assay (PredicineBEACON) in patients with newly diagnosed, locally advanced H...
Predicted journal destinations
1
Cancers
57 training papers
2
Frontiers in Oncology
34 training papers
3
PLOS ONE
1737 training papers
4
British Journal of Cancer
22 training papers
5
Clinical Cancer Research
22 training papers
6
eLife
262 training papers
7
Nature Communications
483 training papers
8
BMC Cancer
21 training papers
9
Cancer Medicine
17 training papers
10
Scientific Reports
701 training papers
11
BMJ Open
553 training papers
12
JAMA Network Open
125 training papers
13
Clinical Epigenetics
21 training papers
14
Nature Genetics
72 training papers
15
International Journal of Cancer
18 training papers
16
The Journal of Molecular Diagnostics
24 training papers
17
Diagnostics
36 training papers